DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Banares R, Moitinho E, Piqueras B. et al.
Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Hepatology 1999;
30: 79-83
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.